← Back to headlines
Replimune Announces Layoffs Following FDA Cancer Drug Rejection
Biopharmaceutical company Replimune plans layoffs after the U.S. Food and Drug Administration rejected its cancer drug, impacting the company's workforce and future plans.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Cyclospora Outbreak Linked to Iceberg Lettuce Expands to Three Additional States
2h ago
Australian Woman Gives Birth to Twins Fathered by Two Different Men
4h ago
U.S. FDA Approves Landmark Pancreatic Cancer Drug With Improved Survival Rates
8h ago
West Nile Virus Outbreaks Spread Across Greece and North Macedonia
9h ago